Long-term peritoneal dialysis causes morphologic and functional changes in the peritoneal
membrane. Although mesothelial-mesenchymal transition of peritoneal mesothelial cells is a …

Background Biocompatible peritoneal dialysis (PD) solutions, including neutral pH, low
glucose degradation product (GDP) solutions and icodextrin, have previously been shown to …

Lay summary Peritoneal dialysis (PD) uses the peritoneal membrane for dialysis. The
peritoneal membrane is a thin layer of tissue that lines the abdomen. The lining is used as a …

Background The longevity of peritoneal dialysis (PD) is limited by high rates of technique
failure, some of which stem from peritoneal membrane injury.'Biocompatible'PD solutions …

Abstract Interleukin (IL)-6 has become a major target for clinical intervention in various
autoimmune conditions. Here, drugs including the humanized anti-IL-6 receptor (IL-6R) …

Inflammation is one of the well-recognized nontraditional risk factors that contributes to the
excessive cardiovascular mortality in peritoneal dialysis (PD) patients. Serum C-reactive …

Long-term peritoneal dialysis is associated with alterations in peritoneal function, like the
development of high small solute transfer rates and impaired ultrafiltration. Also …

Long-term peritoneal dialysis (PD) therapy results in functional and structural alteration of
the peritoneal membrane, including epithelial-to-mesenchymal transition (EMT). Interleukin …

腹膜透析(腹透) 相关性腹膜炎为腹透最常见的并发症, 也是腹透失败的常见原因,
严重影响患者的透析质量与预后. 部分腹透相关性腹膜炎患者痊愈后临床预后不佳(包括腹膜炎 …

The peritoneal equilibration test (PET), first described in 1987, is a semiquantitative
assessment of peritoneal transfer characteristics in patients undergoing peritoneal dialysis. It …